Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2575
1.68 %
$ 65.9 M
Market Cap
-0.81
P/E
ADAP - OTHER CURRENT LIABILITIES
Other Current Liabilities ADAP - Adaptimmune Therapeutics plc
38.8 M
LAST VALUE
12.33%
2 YEAR CAGR
13.22%
5 YEAR CAGR
26.40%
10 YEAR CAGR